Latest Breaking News On - Suspected moderate - Page 2 : comparemela.com

Bexotegrast (PLN-74809) was well tolerated over 12 weeks of treatment with few discontinuations and no drug-related severe or serious adverse events .

United statesChristopher keenanClin gastroenterol hepatolUniversity of miami school medicinePliant therapeutics incCorporate communicationsDrug administrationEuropean medicines agencyEnhanced liver fibrosisChief medical officerMayo scoreDemonstrated antifibrotic activitySuspected moderateSevere liver fibrosisItch numerical rating scaleCynthia levy